医学
干预(咨询)
心脏病
重症监护医学
儿科
急诊医学
疾病
梅德林
心力衰竭
心脏缺陷
厄尔尼诺现象
先天性疾病
流行病学
经皮冠状动脉介入治疗
医疗急救
作者
Gabriel L. Perlow,Yanxu Yang,Jessica Knight,Caroline Y. Shi,Amanda S. Thomas,Matt Oster,Lazaros K. Kochilas
标识
DOI:10.1161/circinterventions.125.015719
摘要
BACKGROUND: Mild congenital heart diseases such as atrial septal defect, ventricular septal defect, patent ductus arteriosus, and pulmonary valve stenosis constitute a significant public health problem. Understanding long-term outcomes after interventions for mild congenital heart disease is essential to inform lifelong care. METHODS: We queried the Pediatric Cardiac Care Consortium, a multicenter US-based registry of patients with congenital heart disease interventions, for patients undergoing surgical or transcatheter procedures for atrial septal defect, ventricular septal defect, patent ductus arteriosus, and pulmonary valve stenosis; 17 407 patients were included. Statistical methods included survival analysis using Kaplan-Meier plots, multivariable Cox proportional hazards models for risk factors for death and standardized mortality ratios. RESULTS: There were 115 in-hospital deaths (0.7%), with the remaining patients included in the postdischarge. The 35-year post-discharge survival ranged from 95.5% for pulmonary valve stenosis to 92.1% for ventricular septal defect. Survival patterns differed by lesion and age at intervention, with intervention at 1≤5 years generally associated with more favorable outcomes. Lower weight-for-age at intervention was associated with an increased hazard of death across all shunt lesions but not for pulmonary valve stenosis. Compared with the general population, mortality risk remained elevated for up to 18 to 20 years after intervention. CONCLUSIONS: Long-term survival after intervention for mild congenital heart disease is excellent; yet lesion-specific risks persist for decades. Age and weight-for-age at intervention are associated with survival, together with excess mortality beyond childhood underscore the need for lifelong, lesion-tailored surveillance in this growing population.
科研通智能强力驱动
Strongly Powered by AbleSci AI